Olga Marchenko
Bayer (Germany) · 44 works · 417 citations · h-index 12
Top works
- Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic
- Sample Size Re-estimation Designs In Confirmatory Clinical Trials—Current State, Statistical Considerations, and Practical Guidance
- Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion
- Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via Simulations
- Sources of Safety Data and Statistical Strategies for Design and Analysis: Clinical Trials
- Nine-year change in statistical design, profile, and success rates of Phase II oncology trials
- Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights
- Adaptive Clinical Trials
- Selection of Hypothesis Weights and Ordering When Testing Multiple Hypotheses in Clinical Trials
- Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion
- Practical designs for Phase I combination studies in oncology
- Sources of Safety Data and Statistical Strategies for Design and Analysis: Transforming Data Into Evidence
- Monitoring rules for toxicity in Phase II oncology trials
- Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials
- Tumor-Agnostic Approvals: Insights and Practical Considerations
- Bridging data across studies using frequentist and Bayesian estimation
- Statistical Considerations for Cardiovascular Outcome Trials in Patients with Type 2 Diabetes Mellitus
- Evaluation and Review of Strategies to Assess Cardiovascular Risk in Clinical Trials in Patients with Type 2 Diabetes Mellitus
- Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia
- Advances in Statistical Approaches to Oncology Drug Development